Skip to main content

Table 5 Factors for post-transplant treatment failure in the D(HBsAg+)/R(HBsAg-) group

From: Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients

Logistic regression models

Factors for treatment failure

Status

No. recipients with treatment failure/ total recipients

OR(95% CI)

Model Aa

Pre-transplant donor HBV DNA

Negative

9/59 (15.3%)

1

Positive

9/24 (37.5%)

6.73 (1.62,36.47)

Recipient sex

Female

1/19 (5.3%)

1

Male

17/64 (26.6%)

16.65 (2.07,397.13)

Pre-transplant recipient HBcAb

Negative

11/25 (44.0%)

1

Positive

7/58 (12.1%)

0.08 (0.02,0.31)

Anti-viral prophylaxis

No

4/18 (22.2%)

1

Yes

14/65 (21.5%)

0.66 (0.13,3.43)

Model Bb

Pre-transplant donor HBV DNA

Negative

9/59 (15.3%)

1

Positive

9/24 (37.5%)

5.95 (1.55,29.39)

Recipient sex

Female

1/19 (5.3%)

1

Male

17/64 (26.6%)

17.10 (2.14,407.15)

Pre-transplant recipient HBcAb

Negative

11/25 (44.0%)

1

Positive

7/58 (12.1%)

0.08 (0.02,0.31)

  1. OR odds ration, CI confidence interval
  2. a Lowest Akaike information criterion (71.11)
  3. b Lowest Bayesian information criterion (80.94)